The largest database of trusted experimental protocols

Countess cell counter

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Countess cell counter is a compact and automated instrument designed for cell counting and viability analysis. It utilizes advanced optics and digital image processing to rapidly determine the number and health of cells in a sample. The Countess provides consistent and reliable cell count data, supporting various applications in cell biology and biomedical research.

Automatically generated - may contain errors

138 protocols using countess cell counter

1

Conditioned Media Effects on Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells in 12-well plates at 4×104 cells per well were cultured overnight in regular media and then placed in conditioned media (diluted 1:1 with fresh media) collected from day-6 or day-9 culture of irradiated or non-irradiated cells. At 72-hour post-culture, viable cells were counted using an automated Countess® Cell Counter (Invitrogen, CA). Average values from triplicate wells were calculated. For pathway activation assay, cells at 72 hours post-culture were analyzed by Western blotting for levels of AKT/phospho-AKT, ERK/phospho-ERK and STAT5/phospho-STAT5. Western blot assay was performed on two biological replicates.
+ Open protocol
+ Expand
2

Culturing Pancreatic Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human pancreatic cancer cell lines MIA PaCa-2, AsPC-1, PANC-1 and BxPC-3 were purchased from American Type Culture Collection (CRL-1420TM, CRL-1682, CRL-1469 and CRL-1687, respectively, ATCC; Rockville, MD, USA) and banked at Centre Paul Strauss. Cells were cultured at 37 °C in a humidified atmosphere containing 5% CO2 and 95% air. PANC-1 was cultured in Dulbecco’s modified Eagle’s medium (DMEM; PAN Biotech GmbH, Aidenbach, Germany) supplemented with 10% fetal bovine serum (FBS, PAN Biotech GmbH) and 1% of a solution of penicillin (10000 IU/mL) and streptomycin (10 mg/mL) (PAN Biotech GmbH). MIA PaCa-2 was cultured in the same conditions with 1% of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 1 mM, PAN Biotech GmbH), 1% of sodium pyruvate (10 mM, PAN Biotech GmbH) and 1% of non-essential amino acids (NEAA, PAN Biotech GmbH). AsPC-1 and BxPC-3 were cultured in Roswell Park Memorial Institute medium (RPMI; PAN Biotech GmbH) supplemented with 10% FBS, and 1% of a solution of penicillin (10000 IU/mL) and streptomycin (10 mg/mL). Subconfluent cell monolayers were trypsinized once a week using 0.5% trypsin containing 2% EDTA (PAN Biotech GmbH) and plated at passage ratios between 0.25:10 to 1:10, according to the cell line or used directly for study after enumeration determined with a Countess® Cell Counter (Countess, Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
3

Cell Viability Measurement Using Trypan Blue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each cell line was plated in a 6-well dish at a density of 105 cells per well. At the time point indicated cells were harvested and mixed with an equivalent volume of 0.4% Trypan blue. Cell counts and viability was measured using a countess cell counter (Invitrogen).
+ Open protocol
+ Expand
4

Colorectal Adenocarcinoma COLO205 2D Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Epithelial colorectal adenocarcinoma COLO205 CCL-222 tumor cells (ATCC, Manassas VA) in 2D cultures were seeded and maintained in RPMI 1640 cell culture medium supplemented with 10% fetal bovine serum (ATCC) and incubated at 37°C with humidified atmosphere of 95% air and 5% CO2. Cell viability prior and during the NBQ48 treatments was determined with an automated Countess Cell counter from Invitrogen using the presto blue (PB) exclusion method. Prior to treatment, cells were sub cultured and kept at a density of 5.0×105 cells per 3.5mL of culture media plus additives in 25cm2 flasks to assure stable metabolic state and exponential growth.
+ Open protocol
+ Expand
5

Evaluating Porphyrin Biocompatibility and Phage Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
H441 cells were seeded into 6-well plates at a concentration of 8.4 × 105 cells/mL and incubated overnight to allow cells to adhere. The next morning, cells were washed and replenished with fresh media, without antibiotics or serum, including the denoted experimental conditions. For ZnPor biocompatibility assessment, the experimental porphyrin was added to the cells at a concentration of 4 or 65 µg/mL. For phage evaluation, H441 cultures were exposed to PEV2 at a concentration that would represent a 1:1 MOI (PsA: phage) in the infection model. All experimental conditions were incubated for 24 h, after which the cells were washed, removed from the cell culture plate via trypsin, and counted using an Invitrogen Countess Cell Counter. Cell viability was determined by comparing experimental conditions against an untreated H441 control. Data is included from three independent experiments.
+ Open protocol
+ Expand
6

Single-Cell Targeted Sequencing of Hematologic Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient samples were thawed and washed with PBS supplemented with 1% BSA (FACS buffer). Cells were incubated with TruStain FcX (Biolegend) for 15 min at 4°C then stained with FITC-conjugated antibodies against human CD3, CD19, and CD56 (NCAM) for 15 min at 4°C. Cells were then washed and resuspended in FACS buffer with DAPI and sorted to isolate viable (DAPI) CD3/CD19/CD56 (FITC) cells using a Sony SH800 Cell Sorter. Cells were resuspended in Tapestri cell buffer and quantified using a Countess cell counter (Invitrogen). Single cells (3–4,000 cells/μL) were encapsulated using a Tapestri microfluidics cartridge, lysed, and barcoded32 . Barcoded samples were then subjected to targeted PCR amplification of a custom 109 amplicons covering 31 genes known to be involved in hematologic malignancies (AML/MPN/MDS; Supplementary Table 1). PCR products were removed from individual droplets, purified with Ampure XP beads (Beckman Coulter), and used as a template for PCR to incorporate Illumina i5/i7 indices. PCR products were purified a second time, quantified via an Agilent Bioanalyzer and pooled to be sequenced. Library pools were sequenced on an Illumina NovaSeq by the MSKCC Integrated Genomics Core.
+ Open protocol
+ Expand
7

Evaluating CCoV Infection Effects on EV

Check if the same lab product or an alternative is used in the 5 most similar protocols
After cell densities reached 70–80% confluency, the viability of the cells was examined via trypan blue assay. The cells were trypsinized, centrifuged, resuspended, and counted using trypsin, 0.4% trypan blue solution, and a Countess cell counter (Invitrogen, Waltham, MA, USA). CRFK cells were seeded at a density of 5 × 105 cells in each cell culture dish and incubated overnight at 37 °C in a 5% CO2 incubator before infection. Overnight cell-free media were discarded and 3 mL of 2% exosome-free medium was added to each dish for infection experiments. Uninfected control dishes were incubated as they were after adding exosome-free media, whereas infection dishes were infected with CCoV at MOI of 400 infectious units (IFU). Plates were incubated for 48 h and 72 h in independent experiments. The cell-free medium from each control and infection dish was collected independently post-incubation and stored at −80 °C for further EV isolation.
+ Open protocol
+ Expand
8

GICs/NSC-2201 Cell Growth Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
GICs or NSC-2201 cells were plated at 50,000 cells per well. Cells were
counted every 3 days by trypan blue exclusion on Countess Cell Counter
(Invitrogen) for 12 days.
+ Open protocol
+ Expand
9

Flow Cytometric Analysis of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The OS cell lines were harvested and cell numbers were determined by utilizing the Countess Cell Counter (Invitrogen) followed by dilution in flow buffer (Dulbecco’s PBS with 0.5% BSA and 0.1% NaN3). The cell suspension was distributed in a 96 well plate with 2 × 105 cells per sample well. Primary antibodies were added in a concentration of 10 μg/ml and cells were incubated at 4°C for 30 min before three washes in 200 μl flow buffer. Secondary antibody, anti-mouse IgG F(ab’)2 fragment-FITC (Sigma-Aldrich, St Louis, MO, USA) or anti-human IgG-FITC (US Biologicals, Salem, MA, USA), was added and incubated for 30 min and washed as in the previous step. All wash steps were performed by centrifugation at 1,200 rpm for 5 min.
Washed cell pellets were dissolved in flow buffer and analyzed in a FACS Calibur (BD Bioscience, Franklin Lakes, NJ, USA) or Guava EasyCyte HT flow cytometer (Merck Millipore, Darmstadt, Germany). The flow analysis was replicated and reproduced at least three times for all cell lines. The data were analyzed with Kaluza Analysis 1.3 software (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
10

HPV-18E2 Protein Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS cells were transfected with 1 µg of the pQMN-18E2, pQMCF-1-18E8E2, pQMCF-1-18E2C1, and pQMCF-1-18E2C2 expression vectors. At 36 h hours post-transfection, the cells were detached with PBS containing 3 mM EDTA and counted with a Countess Cell Counter (Invitrogen). The cells were then collected by centrifugation (200 g for 5 minutes), resuspended in RIPA buffer containing 1X protease inhibitor cocktail (Roche) and sonicated. The lysate was incubated with 30 µl of streptavidin-coated magnetic beads (Dynabeads M250) for 2 hours. The beads were collected, and each lysate was transferred to a new tube with 2 µg of biotinylated chicken HPV-18E2C antibody that had been raised against the C-terminal domain of the HPV18 E2 protein and incubated overnight at 4°C end-over-end. The next day, 50 µl of streptavidin-coated magnetic beads were blocked in 3% BSA-PBS for 2 hours, washed with PBS, added to the lysate and incubated for 4 hours at 4°C. The beads were then collected and washed 3 times in RIPA buffer containing 1x protease inhibitor cocktail (Roche). A total of 10 µl of 1x Laemmli buffer with 1 mM DTT was added per 3*10ˇ6 cells. Western blotting was performed as described in [24] (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!